Publication | Closed Access

Synthetic studies on Sch 202596, an antagonist of the galanin receptor subtype GalR1: an efficient synthesis of (±)-geodin, the spirocoumaranone part of Sch 202596

Molecular PharmacologySch 202596BiochemistrySpirocoumaranone PartSynthetic StudiesMedicineG Protein-coupled ReceptorPeptide SciencePharmacotherapyPharmacologyPharmaceutical ChemistryDrug Discovery